Voyager (VOYG) Insider Files Option Grant — 7,500 Shares
Rhea-AI Filing Summary
Matthew Magana, identified as an officer and director of Voyager Technologies, Inc. (VOYG), reported an award of a stock option on 08/21/2025. The option covers 7,500 shares of Class A Common Stock with an exercise price of $30.59. The filing states the option vests 25% on August 21, 2026 and the remaining shares vest in 36 substantially equal monthly installments thereafter.
The transaction was reported on Form 4 and signed by an attorney-in-fact on 08/22/2025. The filing lists Magana's title as President, Defense & National Security and shows the reported ownership form as Direct.
Positive
- Option grant disclosed: The filing explicitly reports a stock option covering 7,500 shares at an exercise price of $30.59.
- Clear vesting schedule: Vesting is specified as 25% on 08/21/2026 and the remainder in 36 monthly installments thereafter.
- Timely reporting: Form 4 was executed and filed with a signature by attorney-in-fact on 08/22/2025.
Negative
- None.
Insights
TL;DR: Officer filed a standard option grant for 7,500 shares at $30.59 with multi-year vesting; disclosure appears routine.
The Form 4 reports an option grant dated 08/21/2025 to a named officer totaling 7,500 underlying Class A shares at an exercise price of $30.59. Vesting is explicitly defined: 25% after one year (08/21/2026) and the remainder in 36 monthly installments, which clarifies future dilution timing. Reporting and signature were completed on 08/22/2025 by an attorney-in-fact. From a reporting perspective, the filing supplies required detail on quantity, price, vesting schedule, and direct ownership form; no additional compensatory terms or anomalies are disclosed in the document.
TL;DR: Disclosure shows a typical executive option grant with explicit vesting; nothing in the filing indicates unusual governance concerns.
The filing names the recipient and role, quantifies the award, and provides a clear vesting timetable. The record shows direct beneficial ownership following the grant and a timely Form 4 filing. There are no statements in the filing about acceleration provisions, performance conditions, or related-party pecuniary terms beyond those listed, so governance implications are limited to the disclosed grant details.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 7,500 | $0.00 | -- |
Footnotes (1)
- [object Object]